QUALEVITA, founded in 2011, is a premium longevity clinic network dedicated to Making Proactive Health Accessible. The company offers a unique blend of evidence-based medicine with a hospitality-level experience, primarily through medically safe IV infusions and advanced health programs that rely on biomarker diagnostics.
Their personalized health plans are designed to guide clients toward a healthier lifestyle. With clinics located in Amsterdam and services available through on-site visits, QUALEVITA extends its offerings to both individuals and organizations. Corporates can benefit from bespoke services like the On-Site IV Day and Executive Biomarker Day tailored for leadership teams.
While headquartered location and previous investment details are unavailable, the company offers a premium health program priced at €3950. Despite the absence of recent investors or funding rounds, QUALEVITA's strategic service offerings in the expanding proactive health market indicate significant potential for future growth and investor interest.